The characterisation of a rare immune cell has revealed its role in autoimmune diseases and long-term immunity in a recent study.
The cells, know as T Follicular helper cells, represent less than half a percent of the body’s immune cells. They have the ability to “remember” infections, so they’re well equipped to respond quickly to future attacks.
They also have a strong presence in the occurrence of chronic inflammatory disease, suggesting they should be targeted in any developing treatments.
The T Follicular cells and their involvement in antibody production could lead to improved vaccinations and new treatments for immune disorders.
Read more at Walter and Eliza Hall Institute